(Source: MARKETWIRE)
BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE: BM) today announced that the board of directors has approved the issuance of 2,400,000 options to purchase common shares of the Company to ten directors, employees and consultants of the Company. The exercise price of the options is $0.10. They are subject to a four-month hold and have a term of 5 years.
The total number of outstanding options under the Company's plan is 8,365,000 or approximately 9.97% of the outstanding shares.
BACTECH PROFILE
BacTech owns patented bacterial oxidation technology for the treatment of refractory ores and concentrates to enhance the recovery of gold, silver and base metals. The Company's focus is the acquisition of equity positions in projects amenable to bioleaching. In June 2008, the Company signed an agreement to acquire Yamana Gold Inc.'s 33% interest in two refractory gold deposits in Papua New Guinea. In September 2008, BacTech signed an MOU to investigate the use of bioleaching to reprocess arsenic-laden tailings in Cobalt, Ontario. This is the Company's first foray into the cleantech industry. BacTech is continuing to evaluate additional remediation projects.
Shares outstanding 83,857,206
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts: BacTech Mining Corporation Ross Orr President & CEO 416-813-0303 ext 222 416-596-9840 (FAX) info@bactech.com www.bactech.com
SOURCE: BacTech Mining Corporation
A service of YellowBrix, Inc.
